When U.S. foreign aid changed, AIDS workers in Africa felt it
People queue outside the Unjani Clinic in Braamfischerville, Soweto, Johannesburg, South Africa on May 25, 2026. Gulshan Khan for NPR hide caption This essay first appeared in the Up First newslette…
People queue outside the Unjani Clinic in Braamfischerville, Soweto, Johannesburg, South Africa on May 25, 2026. Gulshan Khan for NPR hide caption Th
Read Full Story at NPR News →Why This Matters
The shift in U.S. foreign aid policies isn’t just a bureaucratic adjustment—it represents a fundamental reordering of global health priorities that could reshape decades of progress. For communities on the frontlines of epidemics, these changes aren’t abstract; they determine whether clinics stay open, patients access treatment, and lives are saved or lost.
Background Context
Since the early 2000s, U.S. funding through programs like PEPFAR has been a lifeline for HIV/AIDS treatment and prevention in Africa, accounting for nearly 70% of some countries’ HIV budgets at its peak. The Trump-era cuts and subsequent policy pivots under Biden’s administration—while framed as fiscal responsibility—have left a patchwork of uncertainty, forcing clinics to scramble for alternative funding or shutter services entirely.
What Happens Next
Donor fatigue and shifting geopolitical alliances suggest this trend will accelerate, with African nations forced to diversify funding sources or face critical shortages in antiretroviral supplies. The real test will come in 2026, when the expiration of emergency COVID-era funding could collide with U.S. policy shifts, potentially creating a perfect storm for treatment interruptions.
Bigger Picture
This isn’t just about AIDS—it’s a bellwether for how global health funding is being renegotiated in an era of great-power competition and domestic political polarization. The erosion of predictable, long-term aid threatens to undo years of gains, while also exposing the fragility of relying on a single superpower for survival.
